1. Why gene-by-gene description failed
- Large-scale sequencing shows:
- Each tumor contains hundreds of mutated genes.
- Mutations differ widely across tumors.
- Impossible to analyse cancers meaningfully by memorizing each gene individually.
- Requires a systems/phenotype-level framework, not isolated lists.
Key takeaway:
Cancer = complex network of mutations → must study shared biological behaviours.
2. Hallmark model = modern framework
All cancers acquire a shared set of phenotypic capabilities enabling malignant growth.
Eight fundamental hallmarks
- Self-sufficiency in growth signals
- Oncogenes activated (RAS, MYC)
- Tumor makes or constitutively activates its own GF pathways
- Insensitivity to growth-inhibitory signals
- Loss of tumor suppressors (RB, TP53, TGF-β pathway)
- Cell cycle checkpoints disabled
- Altered cellular metabolism – Warburg effect
- Aerobic glycolysis (glycolysis despite O₂ availability)
- Provides ATP rapidly + biomass precursors for growth
- Evasion of apoptosis
- Mutated TP53
- ↑ anti-apoptotic proteins: BCL-2 family
- Survival even with severe DNA damage
- Limitless replicative potential
- Telomerase reactivation
- Avoid senescence/crisis
- Sustained angiogenesis
- ↑ VEGF, FGF
- Hypoxia-inducible factor (HIF-1) stabilization
- Needed beyond ~1–2 mm thickness
- Invasion & metastasis
- Loss of E-cadherin → loss of adhesion
- Matrix metalloproteinases (MMPs) degrade ECM
- EMT-like phenotype change
- Evasion of immune surveillance
- ↓ MHC I
- ↑ PD-L1 or CTLA-4 signalling
- T-cell anergy/exhaustion
3. Enabling characteristics: accelerate hallmark acquisition
These are not hallmarks themselves, but create fertile ground for malignant evolution:
- Genomic instability
- Defects in DNA repair pathways
- e.g., BRCA1/2 → HR repair defects
- MLH1/MSH2 → mismatch repair defects
- ↑ mutation rate → accelerates other hallmark acquisition
- Cancer-promoting inflammation
- Chronic inflammation recruits immune cells releasing:
- cytokines
- ROS
- growth factors
- proteases
- Creates microenvironment supporting tumor survival and progression
4. Pathogenic gene classes linked to hallmarks
Cancer affects key genetic regulators:
A. Proto-oncogenes → Oncogenes
- Type of mutation: gain-of-function
- Promote hallmark:
- self-sufficient growth signals
Examples:
- RAS, MYC, ABL, EGFR
B. Tumor suppressor genes
- Type of mutation: loss-of-function
- Promote hallmark:
- insensitivity to inhibitory signals
- evasion of apoptosis
Examples:
- RB, TP53, APC, CDKN2A, PTEN
C. DNA repair genes
- Loss → genomic instability enabling mutations across genome
Examples:
- BRCA1/2, MLH1, MSH2
Bottom line:
Each tumor is a sum of accumulating hits in these 3 functional classes → produces malignant phenotype.
5. Hallmark logic in exam questions
When given:
- Oncogene activation → think growth independence
- Tumor suppressor loss → think cell cycle brake failure / apoptosis escape
- DNA repair defects → genomic instability
- PD-L1 signalling → immune evasion
- VEGF/HIF-1 → angiogenesis
- Telomerase activation → immortality
6. Gene/protein writing conventions
- Gene names italicized
- TP53, RB1, MYC
- Protein product plain text
- p53, RB protein, MYC protein
Mnemonic:
blueprint italicized, product non-italicized.
7. Clinical consequence of hallmark model
- Explains why cancer requires multiple mutations (“multi-hit hypothesis”).
- Informs targeted therapy development:
- anti-angiogenic therapy (anti-VEGF)
- immune checkpoint blockade (anti PD-1/PD-L1)
- PARP inhibitors for DNA repair-defective tumors
HALLMARKS OF CANCER — PROPER EXAM REFLEX BLOCK
Use this as a single-glance conversion tool in SBAs & MCQs.
STEM → IMMEDIATE THOUGHT → ANSWER
1. Oncogene activation
Stem clues
- RAS, MYC, EGFR, ABL
- proto-oncogenes → oncogenes (gain-of-function)
- Autocrine growth factor signaling
- Constitutive tyrosine kinase activity
Reflex
→ Self-sufficiency in growth signals
2. Tumor suppressor loss
Stem clues
- RB loss → unchecked G1→S
- TP53 mutation → no DNA damage arrest
- APC loss → unchecked Wnt/β-catenin signalling
- PTEN loss → uninhibited PI3K–AKT–mTOR survival/growth pathway
Reflex
→ Insensitivity to growth-inhibitory signals→ ± Evasion of apoptosis (especially TP53)
3. Glycolysis despite oxygen
Stem clues
- Aerobic glycolysis
- High glucose uptake
- Lactate production with normal O₂
Reflex
→ Altered cellular metabolism (Warburg effect)
4. Survival despite DNA damage
Stem clues
- TP53 mutation - Failure of G1/S arrest after DNA damage
- BCL-2 overexpression- Blocks mitochondrial (intrinsic) apoptosis
- Resistance to chemotherapy-induced apoptosis
Reflex
→ Evasion of apoptosis
5. Unlimited divisions
Stem clues
- Telomerase reactivation
- Avoidance of senescence/crisis
- Immortal cell lines
Reflex
→ Limitless replicative potential
6. Hypoxia response / vessel growth
Stem clues
- VEGF ↑
- HIF-1 stabilization
- Tumor growth beyond 1–2 mm
Reflex
→ Sustained angiogenesis
7. Local invasion or distant spread
Stem clues
- Loss of E-cadherin
- MMP secretion
- EMT-like phenotype
Reflex
→ Invasion & metastasis
8. Immune escape
Stem clues
- ↑ PD-L1 expression-Switches off cytotoxic T-cell killing
- ↑ CTLA-4 signaling-T-cell activation blocked
- ↓ MHC I on tumor cells-Cytotoxic CD8⁺ T cells cannot recognize tumor
- T-cell exhaustion-↓ cytokine production, ↓ cytotoxicity
Reflex
→ Evasion of immune surveillance
ENABLING CHARACTERISTICS — SEPARATE REFLEX
A. DNA repair defects
Stem clues
- BRCA1/2- Defective homologous recombination DNA repair
- MLH1 / MSH2 - Defective DNA mismatch repair
- Microsatellite instability - Accumulation of insertion–deletion mutations
Reflex
→ Genomic instability
→ Accelerates acquisition of all hallmarks
B. Chronic inflammation
Stem clues
- Long-standing inflammation
- Cytokines, ROS, proteases
- Tumor-supportive microenvironment
Reflex
→ Cancer-promoting inflammation
GENE CLASS → FUNCTION REFLEX
- Proto-oncogene → oncogene (gain-of-function)
- Tumor suppressor gene loss (loss-of-function)
- DNA repair gene loss
→ Growth signal autonomy
→ Loss of brakes / apoptosis escape
→ Genomic instability
ONE-LINE EXAM LOCK
Cancer is not a list of genes — it is a set of shared phenotypic behaviours produced by accumulated hits in oncogenes, tumor suppressors, and DNA repair genes